⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15976 | 0.79 | ADRB2 (0.45) | — | |
| SCHEMBL10240 | 0.76 | THRB (0.41) | — | |
| SCHEMBL10455112 | 0.74 | — | — | |
| SCHEMBL3332706 | 0.74 | THRB (0.47) | — | |
| SCHEMBL21581247 | 0.74 | THRB (0.47) | — | |
| SCHEMBL9221661 | 0.74 | THRB (0.47) | — | |
| SCHEMBL14688826 | 0.74 | THRB (0.47) | — | |
| SCHEMBL6909601 | 0.74 | THRB (0.47) | — | |
| SCHEMBL493840 | 0.74 | THRB (0.47) | — | |
| SCHEMBL911135 | 0.74 | THRB (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240092822-A1 | PURIFICATION METHODS FOR OLIGOMERIC COMPOUNDS | IONIS PHARMACEUTICALS, INC. (US) | 2024-03-21 | — | — | US | claimed |
| EP-4301766-A1 | PURIFICATION METHODS FOR OLIGOMERIC COMPOUNDS | Ionis Pharmaceuticals, Inc. (US) | 2024-01-10 | — | — | EP | claimed |
| WO-2022187312-A1 | PURIFICATION METHODS FOR OLIGOMERIC COMPOUNDS | IONIS PHARMACEUTICALS, INC. (US) | 2022-09-09 | — | — | WO | claimed |
| CN-110523354-B | Preparation method of microreactor containing immobilized catalyst | 浙江大学 | 2021-01-19 | — | — | CN | claimed |
| US-8846915-B2 | Process for the manufacture of rosuvastatin calcium using crystalline rosuvastatin ethyl ester | AUROBINDO PHARMA LTD. (IN) | 2014-09-30 | — | — | US | claimed |
| US-8759518-B2 | Intermediates for the preparation of HMG CoA reductase inhibitors and processes for the preparation thereof | CADILA HEALTHCARE LIMITED (IN) | 2014-06-24 | — | — | US | claimed |
| US-20130158263-A1 | INTERMEDIATES FOR THE PREPARATION OF HMG COA REDUCTASE INHIBITORS AND PROCESSES FOR THE PREPARATION THEREOF | CADILA HEALTHCARE LIMITED (IN) | 2013-06-20 | — | — | US | claimed |
| EP-2467363-A1 | PROCESS FOR THE MANUFACTURE OF ROSUVASTATIN CALCIUM USING CRYSTALLINE ROSUVASTATIN ETHYL ESTER | Aurobindo Pharma Limited (IN) | 2012-06-27 | — | — | EP | claimed |
| US-20120149905-A1 | PROCESS FOR THE MANUFACTURE OF ROSUVASTATIN CALCIUM USING CRYSTALLINE ROSUVASTATIN ETHYL ESTER | AUROBINDO PHARMA LTD (IN) | 2012-06-14 | — | — | US | claimed |
| WO-2011104725-A2 | HMG-COA REDUCTASE INHIBITORS AND PROCESS FOR THE PREPARATION THEREOF | CADILA HEALTHCARE LIMITED (IN) | 2011-09-01 | — | — | WO | claimed |
| WO-2011021058-A1 | PROCESS FOR THE MANUFACTURE OF ROSUVASTATIN CALCIUM USING CRYSTALLINE ROSUVASTATIN ETHYL ESTER | AUROBINDO PHARMA LIMITED (IN) | 2011-02-24 | — | — | WO | claimed |
| WO-2009118598-A1 | PROCESS FOR THE MANUFACTURE OF ROSUVASTATIN CALCIUM WITH HIGH PURITY | AUROBINDO PHARMA LIMITED (IN) | 2009-10-01 | — | — | WO | claimed |
| EP-4043500-B1 | ETHYLENE·ALPHA-OLEFIN·NON-CONJUGATED POLYENE COPOLYMER, USE THEREOF, AND MANUFACTURING METHOD THEREOF | MITSUI CHEMICALS INC (JP) | 2025-08-13 | — | — | EP | disclosed |
| US-20250243307-A1 | ETHYLENE/a-OLEFIN/5-VINYL-2-NORBORNENE COPOLYMER, COMPOSITION CONTAINING SAID COPOLYMER, AND CROSSLINKED BODY | MITSUI CHEMICALS, INC. (JP) | 2025-07-31 | — | — | US | disclosed |
| WO-2025059373-A1 | NOVEL PHENALKYLAMINES AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS | GILGAMESH PHARMACEUTICALS, INC. (US) | 2025-03-20 | — | — | WO | disclosed |
| EP-4501979-A1 | ETHYLENE/ALPHA-OLEFIN/5-VINYL-2-NORBORNENE COPOLYMER, COMPOSITION CONTAINING SAID COPOLYMER, AND CROSSLINKED BODY | Mitsui Chemicals, Inc. (JP) | 2025-02-05 | — | — | EP | disclosed |
| EP-0293881-A2 | Peptide boronic acid inhibitors of trypsin-like proteases | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1988-12-07 | — | — | EP | disclosed |
| US-4634722-A | CONTACT LENSES FROM PROTECTED ACRYLIC ESTER DERIVATIVES | SYNTEX (U.S.A.) INC. (US) | 1987-01-06 | — | — | US | disclosed |
| US-4401797-A | ADDUCT OF DIHYDROXYPROPYL (METH)ACRYLATE AND BORONIC ACID | SYNTEX (U.S.A.) INC. (US) | 1983-08-30 | — | — | US | disclosed |
| US-4381345-A | Pretreatment of glucose feedstock with reducing agents | UOP INC. (US) | 1983-04-26 | — | — | US | disclosed |